Showing 1 to 3 of 3 results for dronedarone
Evidence-based recommendations on dronedarone (Multaq) for treating non-permanent atrial fibrillation in adults.
This guideline covers diagnosing and managing atrial fibrillation in adults. It includes guidance on providing the best care and treatment for people with atrial fibrillation, including assessing and managing risks of stroke and bleeding.
Evidence-based recommendations on edoxaban (Lixiana) for preventing stroke and systemic embolism in adults with non-valvular atrial fibrillation.View recommendations for TA355